Skip to nav Skip to content

News Releases and Statements

Facebook Twitter LinkedIn Email

IDSA and HIVMA Response to New CDC Guidelines on Doxycycline as Post-Exposure Prophylaxis

IDSA and HIVMA welcome the Centers for Disease Control and Prevention’s guidelines for implementing doxycycline as post-exposure prophylaxis, or doxy PEP, to prevent sexually transmitted infections.

IDSA and HIVMA Response to Uganda Court Decision on the Anti-Homosexuality Act

IDSA and HIVMA are disappointed and alarmed that Uganda’s Constitutional Court upheld the Anti-Homosexuality Act criminalizing LGBTQ individuals and their right to organize, educate and advocate. We are deeply concerned by the impact of the law on Uganda’s HIV response and for people with HIV and vulnerable to HIV in the country.

IDSA Reacts to ID Funding Proposals in the President’s FY2024 Budget Request

IDSA is encouraged that the president’s FY 2025 Budget Request proposes deeper investments in several key IDSA priorities, including the CDC Antibiotic Resistance Solutions Initiative (to prevent, detect, track and contain antimicrobial resistance) and the National Institute of Allergy and Infectious Diseases, though IDSA is advocating for even larger funding increases for these priorities.

IDSA Responds to Funding for ID Programs in FY2024 Health and Foreign Operations Bills

The legislation averts proposed cuts to the National Institute of Allergy and Infectious Diseases and other ID/HIV programs. The bill also includes a one-year extension of expired President’s Emergency Plan for AIDS Relief provisions. IDSA continues to urge Congress to provide sufficient funding in FY 2025 for ID and HIV programs.

Cardiovascular Infection on the Rise: New Multisociety Statement Defines Appropriate Use of PET/CT and SPECT/CT for Evaluation

As use of prosthetic heart valves and implanted cardiac devices has increased, so too has the incidence of cardiovascular infection. While accurate diagnosis of this condition is critical for guiding treatment decisions that can prevent death and significant morbidity,  current assessment strategies have proven insufficient.

IDSA Supports CDC Guidance on Preventing Respiratory Virus Spread

As we enter the fourth year since the first detection of SARS-CoV-2, much has changed. Over 95% of Americans have some degree of immunity either from prior infection, vaccination or both.

IDSA Response to CDC’S Spring 2024 COVID Vaccine Recommendation

Infectious diseases experts strongly encourage an additional COVID-19 vaccine in spring 2024 for people 65 years of age and older as recommended by the Centers for Disease Control and Prevention.

LEAP Fellowship Program Builds ID-Public Health Partnerships

The Leaders in Epidemiology, Antimicrobial Stewardship and Public Health (LEAP) Fellowship program is an effective model for partnerships between early-career infectious diseases physicians and public health departments, according to new research published in Clinical Infectious Diseases.

IDSA & HIVMA on the Passing of ID & HIV Leader Adaora Adimora, MD, MPH, FIDSA

Dr. Adaora Adimora exemplified the difference a single person can make in the world. She was an extraordinary leader, infectious diseases physician, researcher, mentor, advocate and colleague committed to addressing the drivers of HIV-related health disparities with a special focus on women.

IDSA Calls for Substantive Changes to ABIM’s MOC Program

IDSA is calling on the American Board of Internal Medicine to make substantive changes to its Maintenance of Certification program to make it more clinically meaningful, relevant to scope of practice, supportive of continuous learning and inclusive of all physicians practicing within the infectious diseases discipline.

IDSA Statement on 2023 ID Fellowship Match

IDSA congratulates the more than 300 physicians who have matched into an adult or pediatric infectious diseases fellowship. In addition, the number of adult ID fellowship programs continues to grow, providing more opportunities for physicians to train in this essential specialty.

14 Institutions Receive the IDSA Antimicrobial Stewardship Center of Excellence Designation

IDSA has announced the recipients of its Antimicrobial Stewardship Centers of Excellence designation. The 14 awarded institutions have created stewardship programs led by infectious diseases-trained physicians and pharmacists.

This website uses cookies

We use cookies to ensure that we give you the best experience on our website. Cookies facilitate the functioning of this site including a member login and personalized experience. Cookies are also used to generate analytics to improve this site as well as enable social media functionality.